Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Neovasc Inc. (NVCN)

6.15   0.1 (1.65%) 06-26 22:49
Open: 6.2 Pre. Close: 6.05
High: 6.5 Low: 6.15
Volume: 25,848 Market Cap: 17(M)
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.5 - 6.52 6.52 - 6.54
Low: 6.09 - 6.12 6.12 - 6.14
Close: 6.11 - 6.14 6.14 - 6.18

Technical analysis

as of: 2022-06-24 4:42:03 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 7.59     One year: 8.86
Support: Support1: 5.31    Support2: 4.58
Resistance: Resistance1: 6.5    Resistance2: 7.59
Pivot: 5.44
Moving Average: MA(5): 5.75     MA(20): 5.55
MA(100): 8.56     MA(250): 13.83
MACD: MACD(12,26): -0.2     Signal(9): -0.4
Stochastic oscillator: %K(14,3): 88.5     %D(3): 79.3
RSI: RSI(14): 57.7
52-week: High: 23.25  Low: 0.68
Average Vol(K): 3-Month: 17 (K)  10-Days: 21 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NVCN ] has closed below upper band by 8.9%. Bollinger Bands are 27.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sat, 25 Jun 2022
Neovasc Regains Compliance with Nasdaq Minimum Bid Price Rule -

Wed, 22 Jun 2022
Neovasc (NASDAQ:NVCN) Coverage Initiated at - Defense World

Wed, 15 Jun 2022
Does Neovasc Inc (NVCN) Have What it Takes to be in Your Portfolio Wednesday? - InvestorsObserver

Tue, 14 Jun 2022
Neovasc (NASDAQ:NVCN) Shares Cross Below 50-Day Moving Average of $10.30 - Defense World

Tue, 14 Jun 2022 Begins Coverage on Neovasc (NASDAQ:NVCN) - Defense World

Wed, 08 Jun 2022
Neovasc to Participate in Sidoti & Co. Summer Small Cap Virtual Investor Conference -

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 0 (M)
Shares Float 68 (M)
% Held by Insiders 5.626e+007 (%)
% Held by Institutions 20.9 (%)
Shares Short 519 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -4.18e+007
EPS Est Next Qtl -0.08
EPS Est This Year -0.35
EPS Est Next Year -0.21
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -1
Return on Assets (ttm) 816.4
Return on Equity (ttm) -57.5
Qtrly Rev. Growth 2.3e+006
Gross Profit (p.s.) 4.11
Sales Per Share -26.6
EBITDA (p.s.) -662207
Qtrly Earnings Growth -0.5
Operating Cash Flow 0 (M)
Levered Free Cash Flow -29 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.24
Price to Cash Flow 21.63

Stock Dividends

Dividend 0
Forward Dividend 402760
Dividend Yield 0%
Dividend Pay Date 2019-07-01
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.